Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Organizational effectiveness: a key to R&D productivity

Nature Reviews Drug Discovery volume 15, pages 441–442 (2016)Cite this article

Subjects

Abstract

While the pharmaceutical industry overall has faced huge challenges in drug R&D in recent years, some major companies have consistently been much more productive than average. Here, we highlight 'organizational effectiveness' as a key factor underlying this superior performance and explain how it can be enhanced.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Scannell, J.W. et al. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11, 191–200 (2012).

    Article  CAS  Google Scholar 

  2. Tollman, P. et al. Unlocking productivity in biopharmaceutical R&D: The key to outperforming. BCG Perspectives. Jan 2016. https://www.bcgperspectives.com/content/articles/biopharmaceuticals-people-organization-unlocking-productivity-biopharma-r-and-d/

  3. Tollman, P. et al. Can R&D be fixed? Lessons from biopharma outliers. BCG Perspectives. Sep 2011. https://www.bcgperspectives.com/content/articles/biopharmaceuticals_innovation_can_r_and_d_be_fixed/

  4. Morieux, Y. & Tollman, P. Six Simple Rules: How to Manage Complexity Without Getting Complicated. Harvard Business Review Press (2014).

  5. Peck, R.W. et al. Why is it hard to terminate failing projects in pharmaceutical R&D? Nat. Rev. Drug Discov. 14, 663–664 (2015).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The topic of this article is discussed in greater detail by the authors in a recent joint publication by BCG and BMS cited above.

Author information

Authors and Affiliations

  1. The Boston Consulting Group, Inc., Exchange Place, 31st Floor, Boston, 02109, Massachusetts, USA

    Peter Tollman, Valery Panier & Diana Dosik

  2. Bristol-Myers Squibb Company, 345 Park Avenue, New York, 10154, New York, USA

    Paul Biondi & Francis Cuss

Authors
  1. Peter Tollman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valery Panier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diana Dosik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Biondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francis Cuss
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Peter Tollman or Francis Cuss.

Ethics declarations

Competing interests

Francis Cuss and Paul Biondi are full-time employees of Bristol-Myers Squibb. Peter Tollman, Valery Panier and Diana Dosik have, through BCG, prior consulting interests with Bristol-Myers Squibb.

Supplementary information

Supplementary information S1 (box)

Analyses of R&D productivity and organizational effectiveness (PDF 159 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tollman, P., Panier, V., Dosik, D. et al. Organizational effectiveness: a key to R&D productivity. Nat Rev Drug Discov 15, 441–442 (2016). https://doi.org/10.1038/nrd.2016.91

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.91

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research